UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Uptake of direct‐acting antiviral treatment for chronic hepatitis C in Australia

Journal of viral hepatitis, 2018-06, Vol.25 (6), p.640-648

2018

Volltextzugriff (PDF)

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience

Drug and alcohol dependence, 2020-01, Vol.206, p.107705-107705, Article 107705

2020

Volltextzugriff (PDF)

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011

Journal of viral hepatitis, 2014-03, Vol.21 (3), p.198-207

2014

Volltextzugriff (PDF)

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents

Journal of viral hepatitis, 2009-05, Vol.16 (5), p.352-358

2009

Volltextzugriff (PDF)

The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs

Health sociology review, 2024-01, Vol.33 (1), p.104-118

2024

Volltextzugriff (PDF)

HCV reinfection incidence among individuals treated for recent infection

Journal of viral hepatitis, 2017-05, Vol.24 (5), p.359-370

2017

Volltextzugriff (PDF)

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study

Journal of viral hepatitis, 2014-08, Vol.21 (8), p.560-567

2014

Volltextzugriff (PDF)

‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective

The International journal of drug policy, 2022-04, Vol.102, p.103610-103610, Article 103610

2022

Volltextzugriff (PDF)

Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005‐2014: The HITS‐p study

Journal of viral hepatitis, 2017-09, Vol.24 (9), p.733-741

2017

Volltextzugriff (PDF)

Patterns and Characteristics of Hepatitis C Transmission Clusters among HIV-Positive and HIV-Negative Individuals in the Australian Trial in Acute Hepatitis C

Clinical infectious diseases, 2011-03, Vol.52 (6), p.803-811

2011

Volltextzugriff (PDF)

“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting

The International journal of drug policy, 2022-08, Vol.106, p.103746-103746, Article 103746

2022

Volltextzugriff (PDF)

Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel

The International journal of drug policy, 2021-12, Vol.98, p.103379-103379, Article 103379

2021

Volltextzugriff (PDF)

Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection

Journal of viral hepatitis, 2018-10, Vol.25 (10), p.1180-1188

2018

Volltextzugriff (PDF)

Addressing reimbursement disparities for direct-acting antiviral therapies for hepatitis C virus infection is essential to ensure access for all

Journal of viral hepatitis, 2016-09, Vol.23 (9), p.664-666

2016

Volltextzugriff (PDF)

The path towards hepatitis C elimination in Australia following universal access to interferon-free treatments

Journal of hepatology, 2017, Vol.66 (1), p.S291-S292

2017

Volltextzugriff (PDF)

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach

Journal of viral hepatitis, 2018-01, Vol.25 (1), p.28-36

2018

Volltextzugriff (PDF)

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia

Journal of viral hepatitis, 2011-04, Vol.18 (4), p.e104-e116

2011

Volltextzugriff (PDF)

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study

Journal of viral hepatitis, 2018-05, Vol.25 (5), p.473-481

2018

Volltextzugriff (PDF)

Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study

The International journal of drug policy, 2021-10, Vol.96, p.103421-103421, Article 103421

2021

Volltextzugriff (PDF)

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study

The International journal of drug policy, 2015-10, Vol.26 (10), p.984-991

2015

Volltextzugriff (PDF)

No evidence for higher risk of hepatocellular carcinoma occurrence or recurrence following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression

Journal of hepatology, 2017, Vol.66 (1), p.S12-S12

2017

Volltextzugriff (PDF)

Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

Addiction (Abingdon, England), 2018-10, Vol.113 (10), p.1905-1926

2018

Volltextzugriff (PDF)

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study

Journal of viral hepatitis, 2015-11, Vol.22 (11), p.914-925

2015

Volltextzugriff (PDF)

Injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting, 2005–2014: the HITS-p study

Journal of hepatology, 2017, Vol.66 (1), p.S488-S488

2017

Volltextzugriff (PDF)

Phylogenetic analysis of full‐length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study

Journal of viral hepatitis, 2017-01, Vol.24 (1), p.43-52

2017

Volltextzugriff (PDF)

1 – 25 von 409

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(402)
Mit Volltextzugriff
(378)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(255)
Life Sciences & Biomedicine
(242)
Humans
(201)
Hepatitis C
(154)
Male
(123)
Female
(121)
Hepatitis C Virus
(119)
Adult
(108)
Hepatitis
(103)
Infectious Diseases
(102)
Gastroenterology & Hepatology
(100)
Antiviral Agents - Therapeutic Use
(75)
Hepatitis C - Drug Therapy
(71)
Infections
(67)
Middle Aged
(67)
Substance Abuse, Intravenous - Complications
(64)
Substance Abuse
(58)
Hepatitis C - Epidemiology
(57)
Gastroenterology And Hepatology
(56)
Hepacivirus - Genetics
(56)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Uptake of direct‐acting antiviral treatment for chronic hepatitis C in Australia

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents

The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs

HCV reinfection incidence among individuals treated for recent infection

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study

‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective

Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005‐2014: The HITS‐p study

Patterns and Characteristics of Hepatitis C Transmission Clusters among HIV-Positive and HIV-Negative Individuals in the Australian Trial in Acute Hepatitis C

“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting

Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel

Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection

Addressing reimbursement disparities for direct-acting antiviral therapies for hepatitis C virus infection is essential to ensure access for all

The path towards hepatitis C elimination in Australia following universal access to interferon-free treatments

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study

Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study

No evidence for higher risk of hepatocellular carcinoma occurrence or recurrence following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression

Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study

Injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting, 2005–2014: the HITS-p study

Phylogenetic analysis of full‐length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study

Suchergebnisse filtern